The futility of genomic counseling: essential role of electronic health records.

Abstract:

:Technological advances over the past several years have dramatically reduced the cost of whole-genome sequencing. At the same time, understanding of the functional significance of genetic variation has advanced considerably. The routine generation of whole-genome sequence data for individual patients will soon be sufficiently cost-effective for widespread clinical integration. Yet, the clinical utility of whole-genome data is currently limited by an inability to effectively process, store, interpret and update genomic data, while at the same time protecting patient privacy. Enter the electronic health record. We propose that without the integration of a dynamic uniform electronic health record, counseling patients on the basis of genome-wide data will be futile.

journal_name

Genome Med

journal_title

Genome medicine

authors

Belmont J,McGuire AL

doi

10.1186/gm48

subject

Has Abstract

pub_date

2009-05-08 00:00:00

pages

48

issue

5

issn

1756-994X

pii

gm48

journal_volume

1

pub_type

社论
  • Mining the literature: new methods to exploit keyword profiles.

    abstract:UNLABELLED:Bibliographic records in the PubMed database of biomedical literature are annotated with Medical Subject Headings (MeSH) by curators, which summarize the content of the articles. Two recent publications explain how to generate profiles of MeSH terms for a set of bibliographic records and to use them to defin...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm382

    authors: Andrade-Navarro MA

    更新日期:2012-10-30 00:00:00

  • CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling.

    abstract::CRISPR/Cas9 has revolutionized cancer mouse models. Although loss-of-function genetics by CRISPR/Cas9 is well-established, generating gain-of-function alleles in somatic cancer models is still challenging because of the low efficiency of gene knock-in. Here we developed CRISPR-based Somatic Oncogene kNock-In for Cance...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-019-0627-9

    authors: Mou H,Ozata DM,Smith JL,Sheel A,Kwan SY,Hough S,Kucukural A,Kennedy Z,Cao Y,Xue W

    更新日期:2019-04-16 00:00:00

  • The prognostic potential of alternative transcript isoforms across human tumors.

    abstract:BACKGROUND:Phenotypic changes during cancer progression are associated with alterations in gene expression, which can be exploited to build molecular signatures for tumor stage identification and prognosis. However, it is not yet known whether the relative abundance of transcript isoforms may be informative for clinica...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-016-0339-3

    authors: Trincado JL,Sebestyén E,Pagés A,Eyras E

    更新日期:2016-08-17 00:00:00

  • Network strategies to understand the aging process and help age-related drug design.

    abstract::Recent studies have demonstrated that network approaches are highly appropriate tools for understanding the extreme complexity of the aging process. Moreover, the generality of the network concept helps to define and study the aging of technological and social networks and ecosystems, which may generate novel concepts...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm90

    authors: Simkó GI,Gyurkó D,Veres DV,Nánási T,Csermely P

    更新日期:2009-09-28 00:00:00

  • Open science versus commercialization: a modern research conflict?

    abstract:BACKGROUND:Efforts to improve research outcomes have resulted in genomic researchers being confronted with complex and seemingly contradictory instructions about how to perform their tasks. Over the past decade, there has been increasing pressure on university researchers to commercialize their work. Concurrently, they...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm316

    authors: Caulfield T,Harmon SH,Joly Y

    更新日期:2012-02-27 00:00:00

  • Text-mining clinically relevant cancer biomarkers for curation into the CIViC database.

    abstract:BACKGROUND:Precision oncology involves analysis of individual cancer samples to understand the genes and pathways involved in the development and progression of a cancer. To improve patient care, knowledge of diagnostic, prognostic, predisposing, and drug response markers is essential. Several knowledgebases have been ...

    journal_title:Genome medicine

    pub_type: 杂志文章,meta分析

    doi:10.1186/s13073-019-0686-y

    authors: Lever J,Jones MR,Danos AM,Krysiak K,Bonakdar M,Grewal JK,Culibrk L,Griffith OL,Griffith M,Jones SJM

    更新日期:2019-12-03 00:00:00

  • The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls.

    abstract:BACKGROUND:The R620W variant in protein tyrosine phosphatase non-receptor 22 (PTPN22) is associated with rheumatoid arthritis (RA). The PTPN22 gene has alternatively spliced transcripts and at least two of the splice forms have been confirmed to encode different PTPN22 (LYP) proteins, but detailed information regarding...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm301

    authors: Ronninger M,Guo Y,Shchetynsky K,Hill A,Khademi M,Olsson T,Reddy PS,Seddighzadeh M,Clark JD,Lin LL,O'Toole M,Padyukov L

    更新日期:2012-01-20 00:00:00

  • Ultradeep analysis of tumor heterogeneity in regions of somatic hypermutation.

    abstract::Tumor heterogeneity is of growing importance in the treatment of cancers. Mutational hot spots are prime locations for determining number and proportions of low variant allele frequency (VAF) tumor subclones by next generation sequencing. Low VAF detection is complicated by poor mapping efficiency in regions with high...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0147-1

    authors: Spence JM,Spence JP,Abumoussa A,Burack WR

    更新日期:2015-03-12 00:00:00

  • Interrogating the "unsequenceable" genomic trinucleotide repeat disorders by long-read sequencing.

    abstract::Microsatellite expansion, such as trinucleotide repeat expansion (TRE), is known to cause a number of genetic diseases. Sanger sequencing and next-generation short-read sequencing are unable to interrogate TRE reliably. We developed a novel algorithm called RepeatHMM to estimate repeat counts from long-read sequencing...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0456-7

    authors: Liu Q,Zhang P,Wang D,Gu W,Wang K

    更新日期:2017-07-18 00:00:00

  • Multi-locus models of genetic risk of disease.

    abstract:BACKGROUND:Evidence for genetic contribution to complex diseases is described by recurrence risks to relatives of diseased individuals. Genome-wide association studies allow a description of the genetics of the same diseases in terms of risk loci, their effects and allele frequencies. To reconcile the two descriptions ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm131

    authors: Wray NR,Goddard ME

    更新日期:2010-02-02 00:00:00

  • An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets.

    abstract::During COVID-19, diagnostic serological tools and vaccines have been developed. To inform control activities in a post-vaccine surveillance setting, we have developed an online "immuno-analytics" resource that combines epitope, sequence, protein and SARS-CoV-2 mutation analysis. SARS-CoV-2 spike and nucleocapsid prote...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00822-6

    authors: Ward D,Higgins M,Phelan JE,Hibberd ML,Campino S,Clark TG

    更新日期:2021-01-07 00:00:00

  • Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.

    abstract:BACKGROUND:Studies of cancer mutations have typically focused on identifying cancer driving mutations that confer growth advantage to cancer cells. However, cancer genomes accumulate a large number of passenger somatic mutations resulting from various endogenous and exogenous causes, including normal DNA damage and rep...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00745-2

    authors: Kim YA,Wojtowicz D,Sarto Basso R,Sason I,Robinson W,Hochbaum DS,Leiserson MDM,Sharan R,Vadin F,Przytycka TM

    更新日期:2020-05-29 00:00:00

  • DNA methylation signature in blood mirrors successful weight-loss during lifestyle interventions: the CENTRAL trial.

    abstract:BACKGROUND:One of the major challenges in obesity treatment is to explain the high variability in the individual's response to specific dietary and physical activity interventions. With this study, we tested the hypothesis that specific DNA methylation changes reflect individual responsiveness to lifestyle intervention...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00794-7

    authors: Keller M,Yaskolka Meir A,Bernhart SH,Gepner Y,Shelef I,Schwarzfuchs D,Tsaban G,Zelicha H,Hopp L,Müller L,Rohde K,Böttcher Y,Stadler PF,Stumvoll M,Blüher M,Kovacs P,Shai I

    更新日期:2020-11-16 00:00:00

  • Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex.

    abstract:BACKGROUND:A comprehensive understanding of the pre-existing genetic variation in genes associated with antibiotic resistance in the Mycobacterium tuberculosis complex (MTBC) is needed to accurately interpret whole-genome sequencing data for genotypic drug susceptibility testing (DST). METHODS:We investigated mutation...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00726-5

    authors: Merker M,Kohl TA,Barilar I,Andres S,Fowler PW,Chryssanthou E,Ängeby K,Jureen P,Moradigaravand D,Parkhill J,Peacock SJ,Schön T,Maurer FP,Walker T,Köser C,Niemann S

    更新日期:2020-03-06 00:00:00

  • Huntington's disease: the case for genetic modifiers.

    abstract::For almost three decades, Huntington's disease has been a prototype for the application of genetic strategies to human disease. HD, the Huntington's disease gene, was the first autosomal defect mapped using only DNA markers, a finding in 1983 that helped to spur similar studies in many other disorders and contributed ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm80

    authors: Gusella JF,MacDonald ME

    更新日期:2009-08-21 00:00:00

  • Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease.

    abstract:BACKGROUND:Alzheimer's disease affects ~13% of people in the United States 65 years and older, making it the most common neurodegenerative disorder. Recent work has identified roles for environmental, genetic, and epigenetic factors in Alzheimer's disease risk. METHODS:We performed a genome-wide screen of DNA methylat...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0258-8

    authors: Watson CT,Roussos P,Garg P,Ho DJ,Azam N,Katsel PL,Haroutunian V,Sharp AJ

    更新日期:2016-01-19 00:00:00

  • Mode and dynamics of vanA-type vancomycin resistance dissemination in Dutch hospitals.

    abstract:BACKGROUND:Enterococcus faecium is a commensal of the gastrointestinal tract of animals and humans but also a causative agent of hospital-acquired infections. Resistance against glycopeptides and to vancomycin has motivated the inclusion of E. faecium in the WHO global priority list. Vancomycin resistance can be confer...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00825-3

    authors: Arredondo-Alonso S,Top J,Corander J,Willems RJL,Schürch AC

    更新日期:2021-01-20 00:00:00

  • Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies.

    abstract:BACKGROUND:The advent of personalized medicine requires robust, reproducible biomarkers that indicate which treatment will maximize therapeutic benefit while minimizing side effects and costs. Numerous molecular signatures have been developed over the past decade to fill this need, but their validation and up-take into...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm385

    authors: Starmans MH,Pintilie M,John T,Der SD,Shepherd FA,Jurisica I,Lambin P,Tsao MS,Boutros PC

    更新日期:2012-11-12 00:00:00

  • Moving pathogen genomics out of the lab and into the clinic: what will it take?

    abstract::Pathogen genomic analysis is a potentially transformative new approach to the clinical and public-health management of infectious diseases. Health systems investing in this technology will need to build infrastructure and develop policies that ensure genomic information can be generated, shared and acted upon in a tim...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0254-z

    authors: Luheshi LM,Raza S,Peacock SJ

    更新日期:2015-12-30 00:00:00

  • Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics.

    abstract::Aberrant DNA methylation, in particular promoter hypermethylation and transcriptional silencing of tumor suppressor genes, has an important role in the development of many human cancers, including renal cell carcinoma (RCC). Indeed, apart from mutations in the well studied von Hippel-Lindau gene (VHL), the mutation fr...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm180

    authors: Morris MR,Maher ER

    更新日期:2010-09-03 00:00:00

  • Genetic and epigenetic insights into fetal alcohol spectrum disorders.

    abstract::The magnitude of the detrimental effects following in utero alcohol exposure, including fetal alcohol syndrome and other fetal alcohol spectrum disorders (FASD), is globally underestimated. The effects include irreversible cognitive and behavioral disabilities as a result of abnormal brain development, pre- and postna...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm148

    authors: Ramsay M

    更新日期:2010-04-28 00:00:00

  • Pancreatic cancer genomics: insights and opportunities for clinical translation.

    abstract::Pancreatic cancer is a highly lethal tumor type for which there are few viable therapeutic options. It is also caused by the accumulation of mutations in a variety of genes. These genetic alterations can be grouped into those that accumulate during pancreatic intraepithelial neoplasia (precursor lesions) and thus are ...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/gm430

    authors: Makohon-Moore A,Brosnan JA,Iacobuzio-Donahue CA

    更新日期:2013-03-28 00:00:00

  • NARD: whole-genome reference panel of 1779 Northeast Asians improves imputation accuracy of rare and low-frequency variants.

    abstract::Here, we present the Northeast Asian Reference Database (NARD), including whole-genome sequencing data of 1779 individuals from Korea, Mongolia, Japan, China, and Hong Kong. NARD provides the genetic diversity of Korean (n = 850) and Mongolian (n = 384) ancestries that were not present in the 1000 Genomes Project Phas...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-019-0677-z

    authors: Yoo SK,Kim CU,Kim HL,Kim S,Shin JY,Kim N,Yang JSW,Lo KW,Cho B,Matsuda F,Schuster SC,Kim C,Kim JI,Seo JS

    更新日期:2019-10-22 00:00:00

  • DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.

    abstract:BACKGROUND:Profiles of DNA methylation of many tissues relevant in human disease have been obtained from microarrays and are publicly available. These can be used to generate maps of chromatin compartmentalization, demarcating open and closed chromatin across the genome. Additionally, large sets of genome-wide transcri...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0443-z

    authors: Simmonds P,Loomis E,Curry E

    更新日期:2017-06-07 00:00:00

  • DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma.

    abstract:BACKGROUND:Organic cation transporters (OCTs) determine not only physiological processes but are also involved in the cellular uptake of anticancer agents. Based on microarray analyses in hepatocellular carcinoma (HCC), SLC22A1/OCT1 mRNA seems to be downregulated, but systematic protein expression data are currently mi...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm298

    authors: Schaeffeler E,Hellerbrand C,Nies AT,Winter S,Kruck S,Hofmann U,van der Kuip H,Zanger UM,Koepsell H,Schwab M

    更新日期:2011-12-23 00:00:00

  • MeCP2 mutations: progress towards understanding and treating Rett syndrome.

    abstract::Rett syndrome is a profound neurological disorder caused by mutations in the MECP2 gene, but preclinical research has indicated that it is potentially treatable. Progress towards this goal depends on the development of increasingly relevant model systems and on our improving knowledge of MeCP2 function in the brain. ...

    journal_title:Genome medicine

    pub_type: 信件,评审

    doi:10.1186/s13073-017-0411-7

    authors: Shah RR,Bird AP

    更新日期:2017-02-17 00:00:00

  • Survey of European clinical geneticists on awareness, experiences and attitudes towards direct-to-consumer genetic testing.

    abstract:BACKGROUND:The advent of direct-to-consumer (DTC) genetic testing (GT) has sparked a number of debates regarding the scientific validity of tests, their broad health and ethical implications for society as well as their legal status. To date, relatively few empirical studies have been published regarding this phenomeno...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm449

    authors: Howard HC,Borry P

    更新日期:2013-05-22 00:00:00

  • Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma.

    abstract:BACKGROUND:Merkel cell carcinoma (MCC) is a highly aggressive neuroendocrine carcinoma of the skin caused by either the integration of Merkel cell polyomavirus (MCPyV) and expression of viral T antigens or by ultraviolet-induced damage to the tumor genome from excessive sunlight exposure. An increasing number of deep s...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00727-4

    authors: Starrett GJ,Thakuria M,Chen T,Marcelus C,Cheng J,Nomburg J,Thorner AR,Slevin MK,Powers W,Burns RT,Perry C,Piris A,Kuo FC,Rabinowits G,Giobbie-Hurder A,MacConaill LE,DeCaprio JA

    更新日期:2020-03-18 00:00:00

  • De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome.

    abstract:BACKGROUND:Molecular diagnostics can resolve locus heterogeneity underlying clinical phenotypes that may otherwise be co-assigned as a specific syndrome based on shared clinical features, and can associate phenotypically diverse diseases to a single locus through allelic affinity. Here we describe an apparently novel s...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm415

    authors: Bainbridge MN,Hu H,Muzny DM,Musante L,Lupski JR,Graham BH,Chen W,Gripp KW,Jenny K,Wienker TF,Yang Y,Sutton VR,Gibbs RA,Ropers HH

    更新日期:2013-02-05 00:00:00

  • Overcoming bias and systematic errors in next generation sequencing data.

    abstract::Considerable time and effort has been spent in developing analysis and quality assessment methods to allow the use of microarrays in a clinical setting. As is the case for microarrays and other high-throughput technologies, data from new high-throughput sequencing technologies are subject to technological and biologic...

    journal_title:Genome medicine

    pub_type: 社论

    doi:10.1186/gm208

    authors: Taub MA,Corrada Bravo H,Irizarry RA

    更新日期:2010-12-10 00:00:00